Japan Tissue Engineering Co., Ltd. Logo

Japan Tissue Engineering Co., Ltd.

Pioneers regenerative medicine with tissue products, CDMO services, and research models.

7774 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
蒲郡市三谷北通6丁目209番地の1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Japan Tissue Engineering Co., Ltd. (J-TEC) is a pioneering biotechnology company focused on the commercialization of regenerative medicine. The company operates through three primary segments: the Regenerative Medicine Business, which develops, manufactures, and sells tissue-engineered medical products such as autologous cultured cartilage; the Custom Development & Manufacturing (CDMO) Business, offering contract services for cell and gene therapy developers; and the LabCyte Business, providing cultured human tissue models for research and safety testing. A member of the Teijin Group, J-TEC was the first company to commercialize regenerative medicine in Japan and aims to establish it as a standard of care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-19 10:05
Post-Annual General Meeting Information
臨時報告書
Japanese 27.0 KB
2025-06-19 07:20
Governance Information
内部統制報告書-第27期(2024/04/01-2025/03/31)
Japanese 21.7 KB
2025-06-19 07:18
Registration Form
確認書
Japanese 8.3 KB
2025-06-19 07:16
Annual Report
有価証券報告書-第27期(2024/04/01-2025/03/31)
Japanese 920.6 KB
2024-11-13 06:09
Regulatory News Service
確認書
Japanese 8.2 KB
2024-11-13 06:07
Interim Report
半期報告書-第27期(2024/04/01-2025/03/31)
Japanese 188.4 KB
2024-06-19 07:50
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2024-06-19 07:48
Governance Information
内部統制報告書-第26期(2023/04/01-2024/03/31)
Japanese 21.5 KB
2024-06-19 07:46
Registration Form
確認書
Japanese 8.3 KB
2024-06-19 07:45
Annual Report
有価証券報告書-第26期(2023/04/01-2024/03/31)
Japanese 907.6 KB
2024-02-13 06:39
Regulatory News Service
確認書
Japanese 8.3 KB
2024-02-13 06:38
Quarterly Report
四半期報告書-第26期第3四半期(2023/10/01-2023/12/31)
Japanese 169.5 KB
2023-11-14 07:22
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-14 07:18
Quarterly Report
四半期報告書-第26期第2四半期(2023/07/01-2023/09/30)
Japanese 195.9 KB
2023-08-10 08:23
Report Publication Announcement
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all Japan Tissue Engineering Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Japan Tissue Engineering Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MEDICOX Co., Ltd. Logo
Developing new drugs and building a distribution platform for healthcare solutions.
South Korea 054180
Medigene AG Logo
Clinical-stage immuno-oncology firm developing TCR-engineered T cell therapies for solid tumors.
Germany MDG1
MedinCell S.A. Logo
Develops long-acting injectable therapies using proprietary technology to impact global health.
France MEDCL
A CDMO for cell therapy and regenerative medicine development & manufacturing.
Japan 2370
Medios AG Logo
Compounding patient-specific therapies and supplying specialty pharma for complex conditions.
Germany ILM1
Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.
South Korea 078160
Medizen Humancare Inc Co., Ltd Logo
Offers DTC genetic testing and genomic analysis for personalized disease risk prediction.
South Korea 236340
Medy-Tox Inc. Logo
Develops and markets botulinum toxins and dermal fillers for global aesthetic & therapeutic use.
South Korea 086900
Meito  Sangyo  Co., Ltd. Logo
Produces food products and specialty chemicals for industrial and pharmaceutical applications.
Japan 2207
Merck KGaA Logo
A science & tech firm in healthcare, life science, and electronics, advancing human progress.
United States of America 6MK

Talk to a Data Expert

Have a question? We'll get back to you promptly.